Repository logo
 
Publication

Pharmacoeconomic analysis methods

2022-08Book part Open access
Simple item page
dc.contributor.authorTonin, Fernanda
dc.contributor.authorLeonart, Leticia P.
dc.contributor.authorCasas, Cesar
dc.date.accessioned2022-09-02T11:48:36Z
dc.date.available2024-09-02T00:30:28Z
dc.date.issued2022-08
dc.description.abstractIn the last years, the growing interest of healthcare professionals, policy-makers, and other stakeholders in enlarging the role of economic evaluations was driven by several factors such as evidence-based healthcare culture, patient-centered actions, and quality-linked incentives, associated with an essential increase in financial constraints and pressures on healthcare budgets. Pharmacoeconomics, as a branch of health economics, focuses on balancing the costs and benefits (i.e., consequences) of intervention towards using limited resources, aiming at maximizing value to patients, healthcare payers, and society. These concepts are part of the Health Technology Assessment process that informs clinical and governmental players about medical, social, and economic implications of the development, diffusion, and health technologies. This chapter aims to provide an overview of the essential concepts in pharmacoeconomic analysis methods, including studies classification (e.g., budget-impact analysis, cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis), types of costs and outcomes, modeling approaches (e.g., decision trees or state transition models), and new trending analysis (e.g., the value of information and value-based healthcare analyses), and additionally discuss some recommendations for future studies towards evidence synthesis and practical application.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationTonin FS, Leonart LP, Casas C. Pharmacoeconomic analysis methods. In: Babar ZU, editor. Encyclopedia of evidence in pharmaceutical public health and health services research in pharmacy. Cham: Springer; 2022.pt_PT
dc.identifier.doi10.1007/978-3-030-50247-8_130-1pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.21/14947
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringer Naturept_PT
dc.relation.publisherversionhttps://link.springer.com/referenceworkentry/10.1007/978-3-030-50247-8_130-1pt_PT
dc.subjectPharmacoeconomicspt_PT
dc.subjectEconomic evaluationspt_PT
dc.subjectCostspt_PT
dc.titlePharmacoeconomic analysis methodspt_PT
dc.typebook part
dspace.entity.typePublication
oaire.citation.endPage19pt_PT
oaire.citation.startPage1pt_PT
person.familyNameTonin
person.givenNameFernanda
person.identifier.ciencia-idD01C-C700-9411
person.identifier.orcid0000-0003-4262-8608
person.identifier.ridO-2050-2017
person.identifier.scopus-author-id56085115800
rcaap.rightsopenAccesspt_PT
rcaap.typebookPartpt_PT
relation.isAuthorOfPublication61ded30e-ecec-4b3e-b953-2293e080ebdd
relation.isAuthorOfPublication.latestForDiscovery61ded30e-ecec-4b3e-b953-2293e080ebdd

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Pharmacoeconomic analysis methods.pdf
Size:
598.26 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ESTeSL - Capítulos ou partes de livros